Version 1 of 4 (1999-08-11 to 2000-01-25) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Corporation: |
SCHERING CANADA INC.
3535 TRANSCANADA HIGHWAY POINTE-CLAIRE, QC H9R 1B4 Canada |
Telephone number: | 905-201-0053 |
Fax number: | 905-201-1686 |
Responsible officer name and position during the period of this registration: | ROGER RP CHAI, HEALTH AFFAIRS MANAGER, CENTRAL CANADA |
Description of activities: | PHARMACEUTICAL RESEARCH, DEVELOPMENT MANUFACTURING AND DISTRIBUTION |
Parent: | The corporation is not a subsidiary of any other parent corporations. |
Coalition | The corporation is not a member of a coalition. |
Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), National Defence (DND), Veterans Affairs Canada (VAC) |
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
Subject Matter: Areas of Concern: | Aboriginal Affairs, Health, Intellectual Property, Science and Technology |
Subject Matter: Particulars: | POLICIES OR PROGRAMS RELATED TO THE PROVISION OF PHARMACEUTICAL BENEFITS TO CLIENTS OF FEDERAL PROGRAMS |